Apheris and Ginkgo Datapoints Launch Antibody Developability Consortium to Advance Drug Discovery with AI

Berlin‑based startup Apheris, together with Ginkgo Datapoints, announced the creation of the Antibody Developability Consortium, bringing together pharma giants such as AbbVie, argenx, Lundbeck and Takeda to contribute proprietary antibody sequences. The consortium will compile a 10,000‑antibody dataset and develop AI models within Apheris’s secure federated infrastructure, allowing members to train and fine‑tune models without exposing raw data. The initiative aims to improve early prediction of developability risks, accelerating antibody drug development.

German Fuel Cell Startup Reverion Raises €154 Million to Build European Factory

German deep‑tech startup Reverion secured a €154 million Series B round led by the Deeptech and Climate Fund Kembara, with participation from Allianz, KfW Capital, aurum Impact and Carbon Equity, to fund a new factory that will create 800 jobs and scale up its high‑efficiency gas‑powered fuel‑cell power plants across Europe.

NUSX establishes Munich hub through UnternehmerTUM partnership to bridge Asian and European deep-tech ecosystems

NUSX, the deep‑tech venture‑building arm of NUS Enterprise, announced a strategic partnership with Germany’s UnternehmerTUM, opening a new outpost in Munich’s Urban Colab. The collaboration will give Singapore‑based deep‑tech startups direct access to European partners, investors and markets, while Munich ventures gain a gateway to Singapore. The partnership also includes plans for reciprocal investment links, talent exchanges and joint venture‑building programmes.